L-Arginine/nitric oxide pathway and oxidative stress in adults with ADHD: Effects of methylphenidate treatment

Introduction: Attention deficit hyperactivity disorder (ADHD) is a mental disorder that was once thought to occur only in children. Meanwhile, it is known that adults can also be affected. The first-line drug in children and adults to treat symptoms of inattention, impulsivity, lack of self-regulation, and hyperactivity is methylphenidate (MPH). Known adverse effects of MPH include cardiovascular problems, such as elevated blood pressure and heart rate. Therefore, biomarkers to monitor potential cardiovascular side effects of MPH are needed. The L- Arginine/Nitric oxide (Arg/NO) pathway is involved in noradrenaline and dopamine release as well as in normal cardiovascular functioning and is therefore a prime candidate for the search of biomarkers. The aim of the present study was to investigate the Arg/NO pathway as well as oxidative stress in adult ADHD patients in plasma and urine and the potential influence of MPH medication.Methods: In plasma and urine samples of 29 adults with ADHD (39.2 & PLUSMN; 10.9 years) and 32 healthy adults serving as controls (CO) (38.0 & PLUSMN; 11.6 years) the major NO metabolites nitrite and nitrate, Arg, the NO synthesis inhibitor asymmetric dimethylarginine (ADMA) and its major urinary metabolite dimethylamine (DMA) as well as malondialdehyde (MDA) were measured by gas chromatography-mass spectrometry.Results: Of the 29 patients with ADHD 14 were currently without MPH treatment (-MPH) and 15 were treated with MPH (+MPH). Plasma nitrate concentrations were significantly higher in patients not treated with MPH vs. CO (-MPH 60.3 & mu;M [46.2-76.0] vs. CO 44.4 & mu;M [35.0-52.7]; p = 0.002), while plasma nitrite tended to be higher in-MPH patients (2.77 & mu;M [2.26-3.27]) vs. CO (2.13 & mu;M [1.50-2.93]; p = 0.053). Additionally, plasma creat-inine concentrations were significantly different, with-MPH showing significantly higher concentrations than the other two groups (-MPH 141 & mu;M [128-159]; +MPH 96.2 & mu;M [70.2-140]; Co 75.9 & mu;M [62.0-94.7]; p < 0.001). Urinary creatinine excretion tended to be lowest in-MPH group vs. +MPH and CO (-MPH 11.4 & PLUSMN; 8.88 mM; +MPH 20.7 & PLUSMN; 9.82 mM; 16.6 & PLUSMN; 7.82 mM; p = 0.076). None of the other metabolites, including MDA, a marker of oxidative stress, showed a difference between the groups. Conclusion: Adult patients with ADHD, who are not treated with MPH (-MPH), showed varied Arg/NO pathway, but Arg bioavailability seemed to be consistent over the groups. Our findings imply that urinary reabsorption may be increase and/or excretion of nitrite and nitrate may be decreased in ADHD, resulting in an increase in the plasma concentration of nitrite. MPH seems to partially reverse these effects by not yet known mechanisms, and does not affect oxidative stress.